Oncology · Phase I

Top sponsors

• Chinese Academy of 70 programs
• First People's Hospital 62 programs
• Takeda 49 programs
• United Therapeutics Europe 41 programs
• BEONE MEDICINES AUS 40 programs
• Regeneron UK 34 programs
• Anaxis Pharma 31 programs
• Chongqing Precision Biotech 27 programs
• Janssen-Cilag International N.V 27 programs
• Novartis India 27 programs
• Boehringer Ingelheim 24 programs
• BRIGHT MINDS BIOSCIENCES 23 programs

1. BI 3011441

   Boehringer Ingelheim

   Solid Tumors, KRAS Mutation

   phase 1 · small molecule · completed

   1 trial →

2. BI 765063

   Boehringer Ingelheim

   Head and Neck Squamous Cell Carcinoma (HNSCC)

   phase 1 · small molecule · active

   1 trial →

3. BI 905711

   Boehringer Ingelheim

   Gastrointestinal Neoplasms

   phase 1 · small molecule · completed

   1 trial →

4. BL-M07D1

   Sichuan Baili Pharmaceutical Co.,

   Breast Cancer

   phase 1 · small molecule · active

   1 trial →

5. BMS-641988 (AR#2)

   Bristol-Myers Squibb

   Prostate Cancer

   phase 1 · small molecule · completed

   1 trial →

6. BMS-906024

   Bristol-Myers Squibb

   Cancer

   phase 1 · small molecule · completed

   1 trial →

7. BMS-986148

   Bristol-Myers Squibb

   Advanced Cancer

   phase 1 · small molecule · completed

   1 trial →

8. BMS-986500

   Bristol-Myers Squibb

   Advanced Solid Tumor

   phase 1 · small molecule · active

   1 trial →

9. BNT116-01

   BioNTech SE

   Advanced non-small cell lung cancer

   phase 1 · other · active

   1 trial →

10. BNT211-01

    BioNTech SE

    Solid Tumors

    phase 1 · small molecule · active

    1 trial →

11. BNT314

    BioNTech SE

    Advanced or metastatic malignant solid tumors

    phase 1 · small molecule · active

    1 trial →

12. BO42203

    Hoffmann-La Roche

    Diffuse large B-cell lymphoma (DLBCL), Grade 3B follicular lymphoma, High grade B-cell lymphoma (HGBL), Epstein-Barr virus−positive DLBCL

    phase 1 · other · active

    1 trial →

13. BO45287

    Hoffmann-La Roche

    Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL)

    phase 1 · other · active

    1 trial →

14. BOSUT-09-24

    Lacuna Pharma Pty Ltd

    myeloid leukemia

    phase 1 · other · active

    1 trial →

15. BP41628

    Hoffmann-La Roche

    Solid Tumors

    phase 1 · other · active

    1 trial →

16. BP43015

    Hoffmann-La Roche

    Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    phase 1 · other · active

    1 trial →

17. BP43131

    Hoffmann-La Roche

    Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma (r/r NHL)

    phase 1 · other · active

    1 trial →

18. BP44382

    Hoffmann-La Roche

    Small Cell Lung Cancer and Neuroendocrine Carcinoma

    phase 1 · other · active

    1 trial →

19. BP44956

    Hoffmann-La Roche

    Advanced and/or Metastatic Solid Tumors

    phase 1 · other · active

    1 trial →

20. BPT567

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 · small molecule · terminated

    1 trial →

21. BPX-601

    Regeneron UK Limited

    Prostate Cancer

    phase 1 · gene therapy · active

    1 trial →

22. BPX-601

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 1 · mab · terminated

    1 trial →

23. BS-02

    Blue Earth Diagnostics Ireland Ltd

    Treatment of human papilloma virus (HPV) associated infections, precancers and cancers

    phase 1 · other · active

    1 trial →

24. BS-03

    Blue Earth Diagnostics Ireland Ltd

    Treatment of human papilloma virus (HPV) associated infections and cancers

    phase 1 · other · active

    1 trial →

25. BZ019

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Large B-cell Lymphoma

    phase 1 · mab · active

    1 trial →

26. Bemarituzumab

    Prime Medicine

    Gastrointestinal Cancer

    phase 1 · mab · completed

    1 trial →

27. Bempegaldesleukin (NKTR-214)

    Nektar Therapeutics UK Limited

    Metastatic Melanoma

    phase 1 · mab · terminated

    1 trial →

28. Bexarotene (Targretin®)

    LIGAND PHARMACEUTICALS INC

    Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

    phase 1 · small molecule · completed

    1 trial →

29. BioTTT001 injection

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Locally Advanced Breast Cancer (LABC)

    phase 1 · mab · terminated

    1 trial →

30. Biological/Vaccine: therapeutic autologous dendritic cells.

    LISATA THERAPEUTICS, INC.

    Kidney Cancer

    phase 1 · mab · terminated

    1 trial →

31. Biological: PD-1

    Hospital Authority, Hong Kong

    Advanced Solid Tumor

    phase 1 · small molecule · active

    1 trial →

32. Brentuximab Vedotin

    Takeda

    Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

    phase 1 · small molecule · terminated

    1 trial →

33. C-TIL051

    Nektar Therapeutics UK Limited

    Metastatic Non Small Cell Lung Cancer

    phase 1 · mab · terminated

    1 trial →

34. C2321001

    Pfizer Australia Pty Ltd

    Castration Resistant Prostate Cancer (CRPC), Follicular Lymphoma (FL), Small Cell Lung Cancer (SCLC), Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 1 · other · active

    1 trial →

35. C2321006

    Pfizer Australia Pty Ltd

    Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma

    phase 1 · other · active

    1 trial →

36. C2321007

    Pfizer Australia Pty Ltd

    small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)

    phase 1 · other · active

    1 trial →

37. C4161006

    Pfizer Australia Pty Ltd

    (HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC), non-small cell lung cancer (NSCLC), ovarian cancer, and triple negative breast cancer (TNBC)

    phase 1 · other · active

    1 trial →

38. C4391010

    Pfizer Australia Pty Ltd

    metastatic/advanced breast cancer

    phase 1 · other · active

    1 trial →

39. C4551007

    Pfizer Australia Pty Ltd

    locally advanced or metastatic ER+/HER2- breast cancer

    phase 1 · other · active

    1 trial →

40. C4551010

    Pfizer Australia Pty Ltd

    locally advanced or metastatic HR+/HER2- breast cancer

    phase 1 · other · active

    1 trial →

41. C4891037

    Pfizer Australia Pty Ltd

    ER+/HER2- breast cancer

    phase 1 · other · active

    1 trial →

42. C4891038

    Pfizer Australia Pty Ltd

    ER+/HER2- Breast Cancer

    phase 1 · other · active

    1 trial →

43. C5911001 - SGN-CD25V

    Pfizer Australia Pty Ltd

    Advanced lymphomas (classic Hodgkin lymphoma [cHL], peripheral T cell lymphoma [PTCL], and diffuse large B cell lymphoma [DLBCL]), Solid tumors (eg, NSCLC, HNSCC, and melanoma)

    phase 1 · other · active

    1 trial →

44. C5951001

    Pfizer Australia Pty Ltd

    advanced solid tumors

    phase 1 · other · active

    1 trial →

45. C6001001

    Pfizer Australia Pty Ltd

    Non-muscle invasive bladder cancer (NMIBC)

    phase 1 · other · active

    1 trial →

46. C6081001

    Pfizer Australia Pty Ltd

    KRAS mutated advanced solid tumors

    phase 1 · other · active

    1 trial →

47. CA011-1010

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumors

    phase 1 · other · active

    1 trial →

48. CA059-001

    Celgene Europe Limited

    Acute Myeloid Leukemia and Myelodysplastic Syndromes

    phase 1 · other · active

    1 trial →

Frequently asked questions